Using an implantable cardiac monitor to detect atrial fibrillation in stroke patients
Official title: Yield of Implantable Cardiac Monitoring Device in Patients With Acute Ischemic Stroke.
Run by National and Kapodistrian University of Athens · NCT05494034 · Data updated 2026-11-12
This study is testing whether an implantable heart monitor can help find atrial fibrillation in stroke patients to see if it can lead to better treatment and prevent future strokes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 100 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | National and Kapodistrian University of Athens Academic / other |
| Locations | 1 site (Athens) |
| Status | Recruiting |
| Started | May 5, 2023 |
| Main results expected | January 1, 2027 |
| Study ends | January 1, 2030 |
| Registry record updated | November 9, 2023 |
| Trial ID | NCT05494034 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients aged 40 years or older who have experienced an acute ischemic stroke or TIA and have a HAVOC score of 4 or higher.
✕Probably not a fit
Patients with known or newly detected atrial fibrillation at the time of hospitalization will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective cohort study aims to investigate the incidence of atrial fibrillation (AF) detected by an implantable cardiac monitoring device in patients who have experienced acute ischemic stroke. Conducted across four tertiary centers in the Athens Metropolitan area, the study will enroll consecutive patients aged 40 years or older diagnosed with acute ischemic stroke or transient ischemic attack (TIA). The research will focus on the association between detected AF, initiation of anticoagulation therapy, and the recurrence of stroke. The study will recruit approximately 200 eligible patients over a four-year period, ensuring informed consent is obtained from participants or their guardians.
Why it matters
Potential benefit: If successful, this study could lead to improved detection and management of atrial fibrillation in stroke patients, potentially reducing the risk of stroke recurrence.
How similar studies have gone: Previous studies have shown success in using implantable cardiac monitors for detecting atrial fibrillation, indicating that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Consecutive acute ischemic stroke or TIA patients aged 40 years or older will be enrolled. * Diagnosis of acute ischemic stroke will be based on clinical and neuroimaging evaluation \[brain computed tomography (CT) scan or magnetic resonance imaging (MRI) scan\]. * Stroke patients of all other etiologies (apart AF) presenting a HAVOC score ≥4 will be included in the study. * Informed consent for participation in the study will be obtained from the patients or guardians of patients. Exclusion Criteria: * Patients with incomplete evaluation will be excluded, as previously described. \[22\] -Patients with known or newly detected AF at hospitalization will also be excluded. * Not providing informed consent.
Where it's running
-
Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Athens, Greece Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effectiveness of a new neurorehabilitation technology for stroke recovery
This study is testing a new rehabilitation technology that uses robots and virtual reality to see if it can help stroke patients recover better than regular therapy.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
Emergency Stroke Unit for treating acute strokes
This study is testing a new Emergency Stroke Unit that uses a mobile MRI to see if it can help treat stroke patients faster and improve their recovery.
-
Monitoring brain-derived tau levels in acute ischemic stroke patients
This study is testing how brain-derived tau levels change in stroke patients over 48 hours to see if it can help understand their condition and improve treatment decisions.
-
Comparing endovascular treatment and medical management for stroke patients with disabilities
This study is testing whether a procedure called endovascular thrombectomy can help stroke patients with existing disabilities feel better compared to just using medication.
-
Evaluating real-world effectiveness of endovascular thrombectomy for stroke in the Asia-Pacific region
This study is testing how well a procedure called endovascular thrombectomy works for adults with a certain type of stroke in real-life situations across the Asia-Pacific region.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.